IMC Chicago’s Nutanix NTNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.75M Buy
93,200
+13,900
+18% +$628K ﹤0.01% 2144
2026
Q1
$3.01M Sell
79,300
-43,900
-36% -$1.85M ﹤0.01% 2212
2025
Q4
$6.37M Sell
123,200
-30,400
-20% -$1.86M ﹤0.01% 1555
2025
Q3
$11.4M Sell
153,600
-45,900
-23% -$3.37M ﹤0.01% 1085
2025
Q2
$15.2M Buy
199,500
+21,900
+12% +$1.58M 0.01% 816
2025
Q1
$12.4M Sell
177,600
-3,000
-2% -$208K 0.01% 795
2024
Q4
$11M Buy
180,600
+45,600
+34% +$2.98M 0.01% 862
2024
Q3
$8M Buy
135,000
+30,200
+29% +$1.66M ﹤0.01% 918
2024
Q2
$5.96M Buy
104,800
+19,700
+23% +$1.21M ﹤0.01% 991
2024
Q1
$5.25M Buy
+85,100
New +$4.91M ﹤0.01% 951

Other funds holding NTNX

IMC Chicago's NTNX Position: Q2 2026 in Review

IMC Chicago reduced its Nutanix (NTNX) stake by 28% in Q2 2026, selling an estimated $375K and leaving 20,996 shares worth $1.07M. The position accounts for ﹤0.01% of the portfolio, ranked #3778.

IMC Chicago first reported a position in NTNX in Q3 2025 and has held it in 4 quarters since. The position peaked at $3.62M in Q4 2025. 564 funds tracked by Wall St. Rank hold NTNX as of Q2 2026.

  • IMC Chicago held 20,996 shares of Nutanix worth $1.07M as of Q2 2026.
  • IMC Chicago sold 8,300 Nutanix shares in Q2 2026, an estimated $375K.
  • Nutanix made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #3778 holding.
  • IMC Chicago first reported a position in Nutanix in Q3 2025 and has held it in 4 quarters since.
  • IMC Chicago's Nutanix position peaked at $3.62M in Q4 2025.
  • 564 funds tracked by Wall St. Rank held Nutanix as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.